Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2022 Apr 28;18(4):e1010167. doi: 10.1371/journal.ppat.1010167

Salmonella enterica serovar Typhimurium chitinases modulate the intestinal glycome and promote small intestinal invasion

Jason R Devlin 1, William Santus 1, Jorge Mendez 1, Wenjing Peng 2, Aiying Yu 2, Junyao Wang 2, Xiomarie Alejandro-Navarreto 1, Kaitlyn Kiernan 1, Manmeet Singh 3, Peilin Jiang 2, Yehia Mechref 2, Judith Behnsen 1,*
Editor: Andreas J Baumler4
PMCID: PMC9049507  PMID: 35482787

Abstract

Salmonella enterica serovar Typhimurium (S. Typhimurium) is one of the leading causes of food-borne illnesses worldwide. To colonize the gastrointestinal tract, S. Typhimurium produces multiple virulence factors that facilitate cellular invasion. Chitinases have been recently emerging as virulence factors for various pathogenic bacterial species, and the S. Typhimurium genome contains two annotated chitinases: STM0018 (chiA) and STM0233. However, the role of these chitinases during S. Typhimurium pathogenesis is unknown. The putative chitinase STM0233 has not been studied previously, and only limited data exists on ChiA. Chitinases typically hydrolyze chitin polymers, which are absent in vertebrates. However, chiA expression was detected in infection models and purified ChiA cleaved carbohydrate subunits present on mammalian surface glycoproteins, indicating a role during pathogenesis. Here, we demonstrate that expression of chiA and STM0233 is upregulated in the mouse gut and that both chitinases facilitate epithelial cell adhesion and invasion. S. Typhimurium lacking both chitinases showed a 70% reduction in invasion of small intestinal epithelial cells in vitro. In a gastroenteritis mouse model, chitinase-deficient S. Typhimurium strains were also significantly attenuated in the invasion of small intestinal tissue. This reduced invasion resulted in significantly delayed S. Typhimurium dissemination to the spleen and the liver, but chitinases were not required for systemic survival. The invasion defect of the chitinase-deficient strain was rescued by the presence of wild-type S. Typhimurium, suggesting that chitinases are secreted. By analyzing N-linked glycans of small intestinal cells, we identified specific N-acetylglucosamine-containing glycans as potential extracellular targets of S. Typhimurium chitinases. This analysis also revealed a differential abundance of Lewis X/A-containing glycans that is likely a result of host cell modulation due to the detection of S. Typhimurium chitinases. Similar glycomic changes elicited by chitinase deficient strains indicate functional redundancy of the chitinases. Overall, our results demonstrate that S. Typhimurium chitinases contribute to intestinal adhesion and invasion through modulation of the host glycome.

Author summary

Salmonella Typhimurium infection is one of the leading causes of food-borne illnesses worldwide. In order for S. Typhimurium to effectively cause disease, it has to invade the epithelial cells lining the intestinal tract. This invasion step allows S. Typhimurium to replicate efficiently, causing further tissue damage and inflammation. In susceptible patients, S. Typhimurium can spread past the intestines and infect peripheral organs. It is essential to fully understand the invasion mechanism used by S. Typhimurium to design better treatments for infection. Here, we demonstrate that the two chitinases produced by S. Typhimurium are involved in this invasion process. We show that S. Typhimurium chitinases interact with surface glycans of intestinal epithelial cells and promote adhesion and invasion. Using a mouse infection model, we show that S. Typhimurium chitinases are required for the invasion of the small intestine and enhance the dissemination of S. Typhimurium to other organs. This study reveals an additional mechanism by which S. Typhimurium invades and causes infection.

Introduction

As a food-borne pathogen, S. Typhimurium colonizes the gastrointestinal tract causing self-limiting gastroenteritis. A critical step in the infection cycle of S. Typhimurium is the invasion of intestinal epithelial cells via the type-3 secretion system-1 (T3SS-1) [1]. Once inside, S. Typhimurium hyper-replicates and triggers pyroptosis of the intestinal epithelial cell, releasing newly formed bacterial cells back into the intestinal lumen, exacerbating infection [2]. Immuno-compromised individuals are more susceptible to infection due to the ability of S. Typhimurium to breach the epithelial barrier and disseminate to peripheral organs, causing a systemic infection [3]. S. Typhimurium expresses a variety of virulence factors that promote this pathogenic lifestyle. These provide functions ranging from aiding in the adhesion to and invasion of intestinal epithelial cells, promoting intracellular survival, and modulating the host immune response [46]. Many of these virulence factors have been studied in detail, while others are continuously being discovered. Two chitinases present in the genome of S. Typhimurium LT2 (NCBI: NC_003197.2), STM0018 (ChiA; GeneID:1251536) and STM0233 (GeneID: 1251751), have been recently proposed as potential virulence factors [7]. Our study uses the ATCC 14028 strain of S. Typhimurium (GenBank: CP001363.1), which has the genomic identifiers STM14_0022 and STM14_0275 for chiA and STM0233, respectively. For the sake of consistency, we will use the LT2 nomenclature to refer to these chitinases.

The main function of chitinases is the hydrolysis of chitin polymers into N-acetyl glucosamine (GlcNAc) oligomers [8]. Chitin is a component of the cuticle of insects and crustaceans and is a part of the fungal cell wall, making it the second most abundant biopolymer in nature. Despite chitin’s prevalence, it is absent in mammalian species [8]. However, chitinases can also demonstrate catalytic activity towards other GlcNAc-containing polysaccharides, such as peptidoglycan [9]. This observation indicates that chitinases may interact with other biologically relevant polysaccharides to serve alternative roles. Interestingly, chitinases and chitin-binding proteins, which lack catalytic activity, are emerging as virulence factors for various pathogenic bacterial species. Legionella pneumophila expresses a chitinase that shows catalytic activity towards mucins and is required for colonization of the lungs [10,11]. The intestinal pathogen Listeria monocytogenes produces a chitinase that modulates inducible nitric oxide synthase (iNOS) expression to facilitate colonization of the liver and spleen [12,13]. Vibrio cholerae produces a chitinase that degrades and allows the utilization of intestinal mucins as a carbon source [14]. V. cholerae also produces a chitin-binding protein that adheres to mucins to promote gastrointestinal colonization [14,15]. Both Adherent-Invasive Escherichia coli (AIEC) and Serratia marcescens produce a chitinase and a chitin-binding protein, respectively, that contribute to the adhesion to intestinal epithelial cells [16,17]. A mammalian chitin-binding protein, Chitinase 3 like 1, has already been implicated in S. Typhimurium infection by promoting the invasion of colonic epithelial cells in vitro and intestinal colonization and dissemination in vivo [18]. These previous studies indicate that the chitinases encoded by S. Typhimurium have the potential to contribute to human infection.

Despite the clear interest in the roles of chitinases during infection, S. Typhimurium chitinases have yet to be studied in detail, and their roles in gastrointestinal infection are still unknown. The putative chitinase STM0233 has not been studied experimentally, and its expression, enzymatic activity, and role during infection are entirely unknown. The expression of chiA has been detected during infection of epithelial cells, murine macrophages, and the gastrointestinal system of chickens [1921]. The enzymatic activity of ChiA has been partially elucidated. As expected, ChiA shows in vitro hydrolytic activity towards chitin. However, ChiA also cleaves N-acetyllactosamine (LacNAc) [22,23], a common component of surface glycoproteins of intestinal epithelial cells. S. Typhimurium chitinases might therefore represent glycoside hydrolases that have flexible specificity and interact with the intestinal glycome. In many surface glycoproteins, LacNAc masks the underlying mannose subunits [24]. Exposing these mannose residues is potentially important for S. Typhimurium pathogenesis. An increase of high-mannose glycans was previously shown to increase the invasion of intestinal epithelial cells in vitro [25,26]. S. Typhimurium also produces a type 1 fimbria (FimH) that binds mannose subunits on surface glycoproteins to facilitate adhesion to host cells [27]. Therefore, we hypothesized that S. Typhimurium chitinases are remodeling the intestinal glycome by removing LaNAc to expose mannose residues that facilitate the adhesion to and invasion of intestinal epithelial cells. Here, we demonstrate that both S. Typhimurium chitinases are required to adhere to and invade intestinal epithelial cells in vitro. In a mouse model, chitinases facilitated small intestinal cell invasion, which contributed to S. Typhimurium dissemination to peripheral organs. The presence of S. Typhimurium chitinases resulted in specific changes in the abundance of GlcNAc-containing N-linked surface glycans, indicating that chitinases cleave these GlcNAc residues. S. Typhimurium chitinases also stimulated host cells to upregulate Lewis X/A-containing glycans and other complex glycan species.

Results

S. Typhimurium chitinases are required for intestinal epithelial cell adhesion and invasion

Since there are no experimental studies on STM0233 and only limited studies of ChiA in the current literature [22,23], we set out to determine the roles of these two chitinases for S. Typhimurium growth, interaction with host cells, and pathogenesis. We first confirmed that both chitinases are expressed by S. Typhimurium in vitro. The expression of STM0233 and chiA mRNA was detectable by RT-qPCR. Wild-type (WT) S. Typhimurium expressed both chitinases under growth conditions relevant to our in vitro studies (LB broth and DMEM/F12 + 10% FBS) (Fig 1A). We observed a 2-fold upregulation of STM0233 in DMEM/F12, but a similar expression of chiA across both media (Fig 1A). We generated single- and double-deletion strains lacking the chitinase encoding genes and confirmed that the strains have similar growth kinetics as WT in rich medium (S1A Fig). One potential role for S. Typhimurium chitinases is the degradation and utilization of dietary chitin as a carbon source. We thus performed growth curves in minimal media supplemented with colloidal chitin but found no difference in the growth of strains lacking chitinases compared to WT (S1B Fig). The lack of a growth defect for the chitinase-deficient strains indicates that S. Typhimurium chitinases are not involved in utilizing chitin as a carbon source.

Fig 1. S. Typhimurium chitinases contribute to intestinal epithelial cell adhesion and invasion in vitro.

Fig 1

(A) mRNA expression of S. Typhimurium chitinases during mid-log phase of growth in LB or DMEM/F12 + 10% FBS measured by RT-qPCR. Expression is normalized to the housekeeping gene gmk. n = 3. (B) Gentamicin protection assay of S. Typhimurium infected (MOI:1) colonic epithelial cells (T84). WT n = 14, ΔinvA n = 14, ΔSTM0233 n = 8, ΔchiA n = 8, ΔSTM0233 ΔchiA n = 8. (C) Gentamicin protection assay of S. Typhimurium infected (MOI:1) small intestinal epithelial cells (IPEC-1). n = 6. (D) Adhesion assay of Cytochalasin D treated (2 μg/mL), S. Typhimurium infected (MOI:1) colonic epithelial cells (T84). WT n = 8, ΔinvA n = 8, ΔSTM0233 n = 8, ΔchiA n = 6, ΔSTM0233 ΔchiA n = 8. (E) Adhesion assay of Cytochalasin D treated (2 μg/mL), S. Typhimurium infected (MOI:1) small intestinal epithelial cells (IPEC-1). n = 6. Bars represent mean ± SD. Statistics: (A) unpaired t-test. (B-E) Stars indicate significance compared to the WT control by (B, D) one-way ANOVA with Dunnett’s multiple comparison test or (C, E) mixed-effect analysis with Dunnett’s multiple comparison test. * = p<0.05, ** = p<0.01.

ChiA’s activity towards LacNAc in vitro indicates that this chitinase has the potential to interact with surface glycoproteins of intestinal epithelial cells [22,23]. Interactions with surface glycoproteins have been previously shown to promote S. Typhimurium invasion [2527]. We, therefore, hypothesized that S. Typhimurium chitinases facilitate the invasion of intestinal epithelial cells to promote infection. We assessed the capabilities of the chitinase-deficient strains to invade epithelial cells of the small intestine (IPEC-1) and colon (T-84) by performing a gentamicin protection assay. An invA (GeneID:1254419) deletion strain was used as a negative control, as it lacks expression of a functional T3SS-1, which is required to invade this cell type [28]. S. Typhimurium strains deficient in only one chitinase showed a trend towards reduced invasion of colonic cells, whereas the strain deficient in both chitinases (ΔSTM0233 ΔchiA) showed a highly significant >70% reduction in invasion compared to WT (Fig 1B). In the small intestinal epithelial cell line IPEC-1, invasion deficiencies of S. Typhimurium strains lacking chitinases were even more evident. Here, strains deficient in only one chitinase also showed a >70% reduction in invasion, similar to the double-chitinase deletion strain (Fig 1C). The complementation of the deleted chitinase genes restored invasion of the chitinase-deficient strains (S2 Fig). Therefore, both STM0233 and ChiA contribute to the invasion of intestinal epithelial cells, and deletion of either chitinase seems to have a greater effect on small intestinal invasion than colonic invasion.

Invasion of intestinal epithelial cells by S. Typhimurium requires successful adhesion and the deployment of the T3SS-1 [29,30]. We, therefore, investigated whether chitinases contribute directly to invasion or if their primary role is influencing adhesion. Intestinal epithelial cells were incubated with cytochalasin D prior to and during infection to inhibit the actin rearrangement required for S. Typhimurium invasion. Cytochalasin D treatment completely blocked the invasion of colonic and small intestinal cells (S3A and S3B Fig). It is currently thought that S. Typhimurium adhesion is mediated by the sequential, transient binding of fimbrial adhesins, followed by a more stable adhesion driven by the deployment of the T3SS-1 [31,32]. We used the ΔinvA mutant as a negative control, as it is known to have an adhesion defect due to its lack of a functional T3SS-1 [31,32]. In colonic epithelial cells, the ΔSTM0233 strain showed a 33% reduction in adhesion compared to WT (Fig 1D), indicating a potentially larger role for STM0233 in adhesion than ChiA. The double-deletion strain also showed a trend toward reduced adhesion (p = 0.0698; Fig 1D). In the small intestinal cell line, the double-deletion strain showed a 50% reduction in adhesion (Fig 1E), similar to the observed 70% reduced invasion (Fig 1C). Although chitinases seem to play a partial role in contributing to colonic adhesion, both chitinases significantly contributed to the adhesion to small intestinal cells.

S. Typhimurium chitinases are required for invasion and colonization of the small intestines in vivo

Given the significant role of chitinases as invasion factors for epithelial cells in vitro, we next explored if chitinases contribute to S. Typhimurium pathogenicity in vivo. We used a streptomycin-pretreatment mouse model (Fig 2A), in which C57BL/6 mice were treated with streptomycin 24 h prior to infection to promote S. Typhimurium colonization of the intestinal tract and to allow S. Typhimurium to trigger intestinal inflammation similar to human infection [33]. We first examined the expression of chitinase genes in colonic luminal samples collected 48 hours post-infection (hpi). The expression of both STM0233 and chiA was significantly upregulated in vivo compared to LB broth (Fig 2B). We further examined S. Typhimurium invasion of the ileum and colon by performing a gentamicin protection assay on intestinal tissue and determined luminal colonization levels. The chitinase-deficient strains displayed markedly reduced invasion of ileal tissue at 48 hpi, with the double-deletion strain showing a 10-fold invasion defect compared to S. Typhimurium WT (Fig 2C). Simultaneously, chitinase-deficient strains also showed a defect in the colonization of the lumen of the ileum (Fig 2C). Surprisingly, there was no defect in the ability of the chitinase-deficient strains to invade colonic tissue or colonize the colon at 48 hpi (Fig 2D). Consistent with this finding, chitinase-deficient strains did not show decreased colonization in fecal samples collected throughout infection (Fig 2D). Therefore the in vivo invasion defect is specific to the small intestines, despite the invasion defect observed during in vitro infection of colonic epithelial cells (Fig 1B).

Fig 2. S. Typhimurium chitinases are required for the colonization and invasion of small intestinal epithelial cells in vivo.

Fig 2

(A) Streptomycin pre-treatment mouse model of S. Typhimurium infection. (B) mRNA expression of S. Typhimurium chitinases extracted from colonic luminal samples collected 48 hpi. Expression is normalized to the housekeeping gene gmk. Expression is represented relative to mid-log expression in LB. n = 5. Bars represent mean ± SD. (C) Luminal samples from the terminal ileum were collected 48 hpi to determine S. Typhimurium colonization. Invasion was determined with a gentamicin protection assay performed on the terminal ileum. (D) S. Typhimurium colonies recovered from fecal samples collected at 8 and 24 hpi. Fecal samples at 48 hpi were collected directly from the lumen of the colon. Invasion of colonic tissue was determined with a gentamicin protection assay. Bars represent geometric mean ± geometric SD. Statistics: (B) one-sample t-test against our null hypothesis (relative expression = 1) (C-D) Stars indicate significance compared to the WT control by one-way ANOVA with Dunnett’s multiple comparison test. * = p<0.05, ** = p<0.01.

S. Typhimurium chitinases are required for dissemination during the early stages of gastrointestinal infection but are dispensable during systemic infection

Early during infection, S. Typhimurium specifically targets M cells and invades Peyer’s patches [34]. S. Typhimurium is then transported to the mesenteric lymph nodes by antigen-presenting cells and eventually colonizes the spleen and liver, entering systemic circulation [35]. We, therefore, investigated the ability of the chitinase-deficient strains to disseminate to peripheral organs during infection. Both the chiA (14-fold) and the double-deletion strain (50-fold) showed significantly reduced colonization of the spleen at 48 hpi compared to WT S. Typhimurium (Fig 3A). Strikingly, for all but one mouse, the double-chitinase deletion strain did not colonize the liver to detectable levels, in contrast to WT S. Typhimurium (Fig 3A). This colonization defect may be due to a direct role of chitinases for S. Typhimurium survival at systemic sites. To rule out this possibility, we administered S. Typhimurium directly into the peritoneum. Without the requirement of intestinal invasion, chitinase-deficient strains were able to colonize the spleen and the liver to a similar extent as WT at both 24 and 48 hpi (Fig 3B). These results indicate that chitinase-mediated invasion of the intestines leads to an increase in dissemination. No colonization defect was detected in the Peyer’s patches or mesenteric lymph nodes at 48 hours post-gastrointestinal infection (Fig 3A). These sites are the first that S. Typhimurium disseminates to during infection [35]. An initial defect in the colonization of the Peyer’s patches or mesenteric lymph nodes due to lower gastrointestinal invasion might thus be masked by bacterial replication.

Fig 3. Chitinase-mediated invasion of intestinal tissue contributes to S. Typhimurium dissemination.

Fig 3

(A) Colonization of the Peyer’s patches, mesenteric lymph nodes, spleen, and liver 48 h after intragastric infection. WT n = 13, ΔSTM0233 n = 8, ΔchiA n = 8, ΔSTM0233 ΔchiA n = 9. (B) Colonization of the spleen and liver 24 h and 48 h after intraperitoneal infection. n = 5. Bars represent geometric mean ± geometric SD. Statistics: Stars indicate significance compared to the WT control by one-way ANOVA with Dunnett’s multiple comparison test. * = p<0.05, *** = p<0.001.

The hypothesis that chitinases are mediators during the early stages of infection is supported by data from an extended infection mouse model (S4A Fig). When mice were infected for 96 h, both WT and chitinase-deficient strains showed similar invasion and colonization of the ileum (S4B Fig). Chitinase-deficient strains were also not defective in their ability to colonize the colon or disseminate to the Peyer’s patches, mesenteric lymph nodes, spleen, or liver (S4C and S4D Fig). Our findings thus far show that chitinases are required during early infection but are dispensable for survival at systemic sites and during later stages of infection once S. Typhimurium has fully established colonization.

S. Typhimurium chitinases are not involved in modulating the innate immune response

Based on the ability of the chitinase produced by Listeria monocytogenes, ChiA, to downregulate the expression of inducible nitric oxide synthase (iNOS) as a mechanism to promote colonization of the liver and spleen [12], we explored if S. Typhimurium chitinases interact with the immune system in a similar manner. We collected cecal tissue from mice infected with WT or chitinase-deficient strains for 48h and analyzed the expression of a panel of genes that are known to be involved in the immune response to S. Typhimurium infection [6,36]. We found no changes in the expression of Nos2 (MGI:97361), Duox2 (MGI:3036280), Cxcl1 (MGI:108068), Ifng (MGI:107656), Il6 (MGI:96559), Il22 (MGI:1355307), Il23 (MGI:1932410), S100a9 (encoding a subunit of the antimicrobial protein calprotectin; MGI:1338947), Lcn2 (MGI:96757), Il1b (MGI:96543), or Tnf (MGI:104798) in mice infected with chitinase-deficient strains compared to WT infected mice (Fig 4A–4K). We detected a 2-fold upregulation of Il17a (MGI:107364) in mice infected with chitinase-deficient strains (Fig 4L). The biological relevance of this differential expression is unclear, as there are no changes in upstream regulators (Il23) or any downstream effectors (Lcn2, Cxcl1, S100a9). We additionally examined the expression of the innate immune genes Cxcl1, Il6, Nos2, Il23a, and Il17a in infected ileal tissue. Here, Cxcl1, Il6, Il23a, and Il17a trended towards higher expression (2–3 fold) in chitinase-deficient S. Typhimurium infected mice, but the difference was not statistically significant (S6A and S6B, S6D, and S6E Fig). Nos2 expression remained similar across all infection groups (S6C Fig). Furthermore, histopathological analysis of small intestinal and cecal tissue showed no differences between mice infected with WT S. Typhimurium and mice infected with chitinase-deficient strains (Figs 4M and 4N, and S5A–S5D). Therefore, the small differences in gene expression do not result in a significant effect on overall inflammation. Given the similarity in immune gene expression and the lack of differential pathological scores, we concluded that the phenotypes observed with chitinase-deficient strains were not driven by an altered immune response.

Fig 4. S. Typhimurium chitinases do not modulate the innate immune response in vivo.

Fig 4

(A-L) mRNA expression of innate immune genes extracted from cecal tissue of S. Typhimurium infected mice 48 hpi. Expression is normalized to the housekeeping gene actb as well as gene expression in uninfected mice. WT n = 8, ΔSTM0233 n = 8, ΔchiA n = 8, ΔSTM0233 ΔchiA n = 4. Bars represent geometric mean ± geometric SD. (M) Histopathological scoring of cecal tissue from S. Typhimurium infected mice 48 hpi. WT n = 8, ΔSTM0233 n = 8, ΔchiA n = 8, ΔSTM0233 ΔchiA n = 9. Tissues were scored for submucosal edema, neutrophil infiltration, goblet cells, and epithelial integrity. Bars represent mean ± SD. (N) Representative images of hematoxylin & eosin stained cecal tissue from S. Typhimurium infected mice 48 hpi. 400x magnification was used for WT and ΔSTM0233 ΔchiA images, 200x magnification was used for ΔchiA and ΔSTM0233 images. Statistics: (A-M) Stars indicate significance compared to the WT control by one-way ANOVA with Dunnett’s multiple comparison test. * = p<0.05, ** = p<0.01.

The presence of wild-type chitinases can rescue mutant colonization and invasion

The chitinases ChiA and STM0233 are predicted to be secreted based on their amino acid sequences [37,38]. We, therefore, hypothesized that the chitinase-deficient strains would be able to utilize WT chitinases to enhance invasion if they are available during infection. We used the streptomycin-pretreatment mouse model to explore the invasive capabilities of the chitinase-deficient S. Typhimurium strain during co-infection with WT S. Typhimurium. After 48 h of co-infection, both strains invaded the colon or ileum at similar levels (Fig 5A and 5B). WT S. Typhimurium still showed higher colonization in the lumen of the ileum (Fig 5B). However, the competitive advantage for WT (2-fold) was drastically reduced compared to the difference in colonization observed during single-infection (39-fold) (Fig 2C). Analyzing organ dissemination also did not reveal a competitive advantage for WT S. Typhimurium (Fig 5C). These data demonstrate that the presence of WT S. Typhimurium can rescue the invasion and colonization defect of the chitinase-deficient strain. The secretion of chitinases would explain the lack of an invasion defect during co-infection, as the chitinase-deficient strain would still be able to utilize secreted WT chitinases.

Fig 5. The presence of WT S. Typhimurium rescues the invasion of chitinase-deficient S. Typhimurium.

Fig 5

Mice infected by oral gavage with a 1:1 ratio of WT and chitinase-deficient S. Typhimurium. (A) S. Typhimurium colonies recovered from fecal samples collected at 8 and 24 hpi. Fecal samples at 48 hpi were collected directly from the lumen of the colon. Invasion of colonic tissue was determined with a gentamicin protection assay. (B) Luminal samples from the terminal ileum were collected 48 hpi to determine S. Typhimurium colonization. Invasion was determined with a gentamicin protection assay performed on the terminal ileum. (C) Colonization of the Peyer’s patches (PP), mesenteric lymph nodes (MLN), spleen, and liver 48 h after intragastric infection. n = 5. Top panels A-C: CFU/mg recovered for WT and chitinase-deficient S. Typhimurium. Bars represent geometric mean ± geometric SD. Bottom panels A-C: the same data expressed as a competitive index, CI = (WT colonization/mutant colonization)/ (WT inoculum/mutant inoculum). Bars represent geometric mean ± geometric SD. Statistics: (Top Row) Paired t-test was performed with the absolute values (Bottom Row) the competitive index was analyzed with a one-sample t-test against our null hypothesis (competitive index = 1). * = p<0.05.

S. Typhimurium chitinases induce specific changes to the surface glycome of infected cells

To examine if S. Typhimurium chitinases directly interact with surface glycoproteins of small intestinal epithelial cells during infection, we analyzed the abundance of glycan species during in vitro infection with WT S. Typhimurium and the chitinase-deficient strains. Infection was performed at an MOI of 1000 to ensure that any glycomic changes would be detectable. We simultaneously performed an invasion assay to confirm that the chitinase-deficient strains also demonstrated the previously observed invasion defect at this higher MOI (S7 Fig). Fig 6A shows a common N-linked glycan species and its saccharide components. Principal component analysis (PCA) revealed distinct groupings for the glycome of uninfected, WT infected, and the chitinase-deficient strain infected cells, indicating that S. Typhimurium chitinases induce specific glycomic changes during infection (Fig 6B). Closer inspection of the changes in the relative abundance of glycans revealed an increase in the abundance of specific glycans when epithelial cells were challenged with the chitinase-deficient strains compared to WT infection. These included various glycans containing GlcNAc, LacNAc, or NeuAc-LacNAc as terminal residues (43100, 45100, 33000, 44000, 34010, 55020) (Fig 6C). We, therefore, hypothesized that S. Typhimurium chitinases might indeed cleave GlcNAc-containing residues on these glycans. However, other GlcNAc-containing glycans were unchanged in relative abundance when chitinases were deleted (S4 Table). S. Typhimurium chitinases may, therefore, be interacting with specific glycan species instead of broadly interacting with all GlcNAc-containing glycans. Surprisingly, ChiA and STM0233 seem to share similar activity towards specific glycan residues, as there are only minor differences in the abundances of individual glycans during infection with the single-deletion strains (Fig 6C and S4 Table).

Fig 6. S. Typhimurium chitinases induce specific changes in the intestinal glycome during infection.

Fig 6

(A) Common N-linked glycan structure. (B) Principal component analysis of the surface glycome composition of uninfected IPEC-1 cells and cells infected with WT S. Typhimurium or the chitinase-deficient strains. Uninfected n = 14, WT n = 6, ΔSTM0233 n = 6, ΔchiA n = 6, ΔSTM0233 ΔchiA n = 6. (C) Relative abundance of glycan species that increase during infection with ΔSTM0233 ΔchiA compared to WT S. Typhimurium. (D) Relative abundance of selected glycans species that increase during WT infection compared to uninfected but do not increase during ΔSTM0233 ΔchiA infection (E) Relative abundance of selected Lewis X/A-containing glycans species that increase during WT infection compared to uninfected but do not increase during ΔSTM0233 ΔchiA infection. (F) Overall relative abundance of Lewis X/A structures on all glycans. A five-digit code is used to represent N-glycan structures. The 1st number denotes the number of hexosamine (HexNAc), i.e. N-acetyl glucosamine. The 2nd number denotes the number of hexose (Hex), i.e. mannose and galactose. The 3rd number denotes the number of fucose (DeoxyHex). The 4th and 5th numbers represent the number two different sialic acid structures, N-acetylneuraminic acid (NeuAc) and N-glycolylneuraminic acid (NeuGc), respectively. Bars represent mean ± SD. Statistics: (C-D) Mann-Whitney U test (F) One-way ANOVA with Dunnett’s multiple comparison test. * = p<0.05, ** = p<0.01, *** = p<0.001.

We also found multiple glycans that increased in abundance upon infection with WT S. Typhimurium but not during infection with the chitinase-deficient strains (Fig 6D and 6E). Many of these are high molecular-weight complex or hybrid glycans (53100, 46110, 56040, 56100, 36100, 58100, 56120) (Fig 6D), including many glycans that contain Lewis X/A structures (55110, 57100, 66100, 67100, 67120) (Fig 6E and 6F). The upregulation of these glycans during WT S. Typhimurium infection indicates modulation of the expression of glycans by host cells. Since these changes do not occur during infection with chitinase-deficient strains, the detection of S. Typhimurium chitinases or their enzymatic activity by host cells may drive these glycomic changes. Overall, this data suggests that S. Typhimurium chitinases modulate the surface glycome during infection via direct enzymatic activity or indirect induction of host cell glycan expression to enhance the adhesion to and invasion of intestinal epithelial cells (Fig 7).

Fig 7. Proposed Model.

Fig 7

STM0233 and ChiA are likely secreted into the small intestinal lumen during infection. STM0233 and ChiA remodel the surface glycome through the removal of GlcNAc residues of N-linked glycans. STM0233 and ChiA also stimulate the upregulation of Lewis X/A-containing glycans by host cells through an unknown mechanism. STM0233 and ChiA enhance S. Typhimurium adhesion to epithelial cells, likely due to the exposure of mannose and increase in Lewis X binding residues. Increased adhesion leads to increased invasion of intestinal epithelial cells and increased dissemination to the spleen and liver.

Discussion

Bacterial chitinases have recently been recognized as virulence factors for various pathogenic species [39]. However, studies of S. Typhimurium chitinases have been mostly limited to the enzymatic activity of ChiA, which was found to cleave chitin, LacNAc, and LacdiNAc molecules [22,23]. A functional role for S. Typhimurium chitinases during infection has been suggested based on the observations that chiA is upregulated during the infection of epithelial cells, murine macrophages, and the chicken gastrointestinal system [1921]. One study, therefore, investigated ChiA’s role in host cell invasion and pathogenicity [40]. Deletion of ChiA resulted in only slightly reduced invasion of non-intestinal epithelial cells and no competitive advantage of wild type S. Typhimurium over ChiA-deficient S. Typhimurium in a mixed infection mouse model, questioning the relevance of S. Typhimurium chitinases for pathogenicity. Our study corroborates these results, as we also show that the role of chitinases is cell-type specific and not apparent in mixed infections. Since our data indicate a functional redundancy of ChiA and STM0233, the deletion of ChiA alone may not have been sufficient to observe a phenotype with this study’s models. Therefore, by using different experimental conditions and examining strains deficient in both chitinases, we were able to elucidate a role for S. Typhimurium chitinases during infection.

One role that has been identified for chitinases in other pathogens is the facilitation of binding to intestinal epithelial cells. ChiA of AIEC is known to enhance the adhesion to intestinal epithelial cells [16]. Chitin-binding proteins of Serratia marcescens (Cbp21) and Vibrio cholera (GbpA) have also been shown to promote adherence to intestinal epithelial cells [17,41]. Here, we demonstrate that both S. Typhimurium chitinases are involved in adhesion to intestinal epithelial cells (Fig 1D and 1E). This role in adhesion likely explains the invasion defect of the chitinase-deficient strains (Figs 1B and 1C, and 2C), as adhesion is a prerequisite of S. Typhimurium invasion [30]. Interestingly, S. Typhimurium chitinases may play a greater role in the adhesion to small intestinal tissue than colonic tissue, based on the larger adhesion/invasion defect in vitro and the lack of a colonic invasion defect in vivo (Figs 1B–1E and 2D). Previous literature has indicated that the binding of S. Typhimurium to a variety of epithelial cell lines is mediated by fimbriae specific to each cell type [42]. This suggests a potential role for chitinases as mediators for the binding of fimbriae specific to the small intestines, such as Pef [43]. Prior to this study, STM0233 had not been studied experimentally. Our data suggest that STM0233 may play a more significant role in adhesion and invasion than ChiA (Fig 1B–1E).

Based on the function of chitinases from other bacterial pathogens, there are a variety of possible explanations as to why S. Typhimurium chitinases enhance adhesion. For one, chitinases could be degrading mucins to provide access to the epithelial layer. Legionella pneumophila produces a chitinase (also named ChiA), which is not homologous to S. Typhimurium ChiA, that degrades mucins present in the lungs to enhance colonization [10,11]. It is now known that the binding of GbpA of Vibrio cholerae to intestinal mucins is responsible for enhanced adhesion to epithelial cells [15]. While interactions with intestinal mucins could potentially contribute to the in vivo colonization and invasion defect (Fig 2C), it does not explain our in vitro results (Fig 1C and 1E) as the IPEC-1 cell line is not known to be a mucin-producing cell line [44]. Therefore, we focused our study on the N-linked glycans present on IPEC-1 cells and did not explore possible interactions with the O-linked glycosylation of mucins.

One possible role for chitinases is the liberation of nutritional resources from intestinal glycans to enhance luminal colonization. Vibrio cholerae produces a chitinase (ChiA2) that can degrade mucins, releasing saccharides that can be used as a carbon source [14]. Members of the commensal microbiota can also use intestinal glycans as a source of nutrients by producing various types of glycosyl hydrolases [45,46]. S. Typhimurium could be using glycans as a nutrient source. However, this seems unlikely since the invasion assays were performed in rich media (Fig 1B–1D), where S. Typhimurium would not require an alternative carbon source to replicate efficiently.

Some bacterial chitinases are known to interact with the host immune system to promote infection. For example, one chitinase produced by Listeria monocytogenes (ChiA) was found to down-regulate nos2 expression during murine infection [12]. L. monocytogenes strains lacking ChiA showed decreased colonization of the spleen and liver during murine infection [12,13]. This observation indicated an extraintestinal role for L. monocytogenes chitinases in modulating inflammation. In our mouse model of S. Typhimurium infection, we detected a minor increase in Il17a expression in chitinase-deficient strain infected mice but no changes in the expression of nos2 or other innate immune genes (Fig 4A–4L). Even though chitinase-deficient strains displayed a colonization defect for the spleen and liver with an intestinal infection model (Fig 3A), there was no colonization defect when S. Typhimurium was delivered directly to the peritoneal cavity (Fig 3B). With this consideration, S. Typhimurium chitinases are likely specifically required for small intestinal infection through a mechanism that does not involve innate immune modulation.

Another possible mechanism for enhanced adhesion is through interactions between bacterial chitinases and the host protein Chitinase 3 like 1 (CH3L1). CH3L1 is a chitin-binding protein expressed by various cell types, such as intestinal epithelial cells [18] and macrophages [47], and is associated with inflammatory bowel disease [48,49]. Both CBP21 of Serratia marcescens and ChiA of AIEC exploit intestinal CH3L1 expression to adhere to epithelial cells [16,17]. CH3L1 appears to play a role in Salmonella infection, as the expression of CH3L1 by colonic epithelial cells was found to enhance Salmonella adhesion and invasion [18]. Our study has not explored the possibility that Salmonella chitinases promote adhesion by interacting with CH3L1 in a similar manner as CBP21 and ChiA of AIEC.

A likely target for bacterial chitinases is the N-linked surface glycoproteins expressed by host cells. S. Typhimurium is already known to trigger the removal of sialic acid during infection of colonic cells, which is likely to be mediated by sialidases expressed by S. Typhimurium [26,50]. Several other glycosyl hydrolases expressed by S. Typhimurium have also been implicated in the modulation of specific glycan species [25]. A previous study showed that WT and the invasion deficient ΔinvA strain induce similar changes in the surface glycome of Caco-2 cells [26]. This similarity suggests that S. Typhimurium invasion does not influence the abundance of glycans on intestinal epithelial cells. We used a different intestinal epithelial cell line (IPEC-1), and it is possible that the response to S. Typhimurium invasion differs and that these cells modulate their glycome dependent on invasion rates, but we did not explore this in this study. Even though ChiA has demonstrated activity towards LacNAc residues [22,23], we did not detect broad removal of LacNAc residues during infection (S4 Table). Instead, we saw the abundance of specific GlcNAc-containing glycans increase during infection with the chitinase-deficient strains (Fig 6C). This pattern indicates that chitinases expressed by WT S. Typhimurium remove these residues, while other GlcNAc-containing glycans are unaffected. Chitinases may only be required for the removal of GlcNAc residues on specific glycoproteins that directly facilitate invasion. This hypothesis is supported by previous observations that the type 1 fimbria, FimH, promotes S. Typhimurium adhesion and invasion of M cells by specifically binding mannose-containing N-linked glycans of surface Glycoprotein 2 (GP2) [51,52]. It has also been shown that the binding of AIEC ChiA to CH3L1 is specifically dependent on the N-glycosylation of CH3L1 [16]. So chitinases may not be required to have broad activity towards all GlcNAc residues. Instead, they could specifically target glycan species that would markedly contribute to invasion.

Furthermore, our data also indicates that host cells are potentially detecting the activity of S. Typhimurium chitinases and are modulating their glycome to compensate. We observed an increase in high molecular-weight complex glycans during infection with WT S. Typhimurium, potentially driven by host cell regulation (Fig 6C). Specifically, there was an increase in additional fucose subunits on terminal LacNAc residues forming Lewis X/A structures (Fig 6D). Increased fucosylation has been observed in a previous glycomic analysis of S. Typhimurium infection, which also identified increased expression of the host cell fucosyltransferases that would be responsible for this fucosylation [25]. It seems that this upregulation of fucosylation is dependent on S. Typhimurium chitinase activity, as the relative abundance of Lewis X/A-containing glycans during chitinase-deficient strain infection is comparable to uninfected cells (Fig 6E and 6F). It is important to note that S. Typhimurium expresses a fimbrial adhesin, Pef, that binds Lewis X structures and is specifically required for small intestinal adhesion [43,53]. Our glycomics analysis does not allow differentiation between the β(1,3)-fucosylation of Lewis X glycans and the β(1,4)-fucosylation of Lewis A glycans. If Lewis X glycans are being upregulated, then S. Typhimurium may exploit these Lewis X structures as an alternative binding site, which would explain the tissue tropism of chitinase-mediated invasion of the small intestines (Fig 2C).

Here we elucidated novel roles for S. Typhimurium chitinases (ChiA and STM0233) in promoting infection by enhancing small intestinal invasion. We have demonstrated that chitinases promote the adhesion to epithelial cells, which likely drives the enhanced invasion. We also showed that chitinases are required for optimal early small intestinal infection and promote increased dissemination of S. Typhimurium into systemic circulation. Increased invasion is linked to modulations of the epithelial cell glycome induced by S. Typhimurium chitinases. Chitinases cause alterations in the abundance of specific GlcNAc-containing glycans that would indicate chitinase-mediated cleavage and increase the abundance of Lewis X/A-containing glycans, likely by stimulating host cell expression.

Materials and methods

Ethics statement

Mouse experiments were performed in accordance with protocols and guidelines approved by the Institutional Animal Care Committee (20–016) of the University of Illinois Chicago.

Bacterial strains

All strains were grown while shaking at 200 rpm in 5 mL of Luria-Bertani (LB) broth (BD Diagnostic Systems) for 16 h at 37°C unless otherwise stated (S1 Table).

Mutant generation

Wild-type S. Typhimurium IR715 was used to generate all deletion strains. Deletion constructs containing an antibiotic resistance cassette flanked by sequences homologous to 1kb upstream and downstream of the target gene on a pGP704 suicide vector backbone were generated by Gibson assembly (S1 Table). Q5 High-Fidelity DNA Polymerase (New England Biolabs) was used for all cloning PCR reactions. The genome of IR715 was used to generate the homologous flanking regions for each gene. The primers used to generate the flanking regions of chiA were chiA_FR1_fwd, chiA_FR1_rev, chiA_FR2_fwd#2, and chiA_FR2_rev#2. The flanking region for STM0233 was generated with the primers STM0233_FR1_fwd, STM0233_FR1_rev, STM0233_FR2_fwd, and STM0233_FR2_rev. The flanking region for invA was generated with the primers invA-LB_FW, invA-LB_RV, invA-RB_FW, and invA-RB_RV. The STM0233 and invA deletion constructs contained a chloramphenicol resistance cassette, while the chiA deletion construct contained a kanamycin resistance cassette. The chloramphenicol resistance cassette was generated by PCR using pKD3 as a template and primers CmR_fwd and CmR_rev for the STM0223 deletion construct and invA-CmR_FW and invA-CmR_RV for the invA deletion construct. The kanamycin resistance cassette was generated by PCR using pKD4 as the template and the primers chiA_KanR_fwd and chiA_KanR_rev#2. pGP704 was digested with the restriction enzymes SalI and EcoRV. The two flanking regions, the antibiotic resistance cassette, and the vector backbone were ligated together using the Gibson Assembly Master Mix (NEBuilder), generating the plasmids pGP704-STM0233::Cm, pGP704-chiA::Kan, and pGP704-invA::Cm. Escherichia coli S17 λpir cells were transformed with either pGP704-STM0233::Cm, pGP704-chiA::Kan, or pGP704-invA::Cm and selected for on LB agar with carbenicillin (0.1 mg/mL). The transformation was done by electroporation (Gene Pulser II, Biorad) using 1 μL of a 1:3 dilution of the assembly reaction (in ultrapure H2O). Single colonies of the resulting E. coli S17 λpir cells containing either pGP704-STM0233::Cm, pGP704-chiA::Kan, or pGP704-invA::Cm were grown in LB broth with carbenicillin (0.1 mg/mL). These E. coli cultures were plated on LB agar with a culture of IR715 at a 1:1 ratio for conjugation. Plates were incubated at 37°C for 16 h, allowing deletion constructs to be transferred to IR715 and the target genes to be replaced with the antibiotic resistance cassette by homologous recombination. The bacterial lawns were harvested, and the resulting deletion strains, ΔSTM0233 and ΔinvA, were selected for on LB agar with nalidixic acid (0.05 mg/mL) and chloramphenicol (0.03 mg/mL). The ΔchiA strain was selected for on LB agar with nalidixic acid (0.05 mg/mL) and kanamycin (0.1 mg/mL). Two PCR reactions were used to confirm that the antibiotic resistance cassettes were inserted into the correct location. The primer sets used for these reactions were C2 and STM0233_FR1_out_Fw, and C1 and STM0233_FR2_out_Rv for ΔSTM0233. The primer sets used for ΔchiA were chiA_out_Fw and K1_(Kan_Rv), and chiA_out_Rv and K3_(Kan_Fw). The primer sets used for ΔinvA were invA_LB_chk_FW and C3, and C1 and invA_RB_chk_RV. The chitinase deletion strains were further examined to confirm that the target genes were deleted. The presence of STM0233 was detected with the primer pair STM0233_pres_Fw and STM0233_pres_Rv, and chiA was detected with the primer pair chiA_pres_Fw and chiA_pres_Rv (S2 Table).

The S. Typhimurium IR715 ΔSTM0233 ΔchiA strain was generated by transduction using the P22 HT105/1 int-201 bacteriophage (S1 Table). A culture of the IR715 ΔchiA strain was infected with P22 HT105/1 int-201 for 8 h at 37°C. The phage was isolated by the centrifugation of the infected culture, and chloroform was added to the collected supernatant. Bacteriophage transduction was performed by plating 200 μL of a 16 h IR715 ΔSTM0233 culture and 1–20 μL of the isolated P22 phage onto LB agar with kanamycin (0.1 mg/mL). Plates were incubated at 37°C overnight, and the resulting colonies of transductants were cross-streaked against the P22 H5 phage on Evans blue-Uranine (EBU) agar to isolate phage-free true lysogens.

Complementation of the chitinase deletion strains was done by transposon-mediated insertion of the full chitinase gene and endogenous promoter into the Tn7 locus [54]. Chitinase genes and their endogenous promoters were amplified using Q5 High-Fidelity DNA Polymerase (New England Biolabs) with wild-type S. Typhimurium IR715 as the template and the primer sets STM0233_Tn7Com_FW and STM0233_Tn7Com_RV or chiA_Tn7Com_FW and chiA_Tn7Com_RV, which carry restriction sites for either XmaI or XhoI on their 5’ end. The gene fragments were sub-cloned into Zero Blunt TOPO PCR vector (Invitrogen) and electroporated into One Shot Top10 cells (Invitrogen). The plasmid containing the cloned chitinase gene was isolated using the Qiaprep spin miniprep kit (Qiagen). Restriction digestion of the plasmid was done with XhoI and XmaI, and the chitinase gene fragment was isolated via gel extraction with the QIAQuick Gel Extraction kit (Qiagen). pGRG36 (a gift from Nancy Craig [54]) was also digested with XhoI and XmaI and extracted via gel extraction using the QIAEX II gel extraction kit (Qiagen). The digested pGRG36 and cloned chitinase gene were ligated together using ElectroLigase (New England Biolabs) and used to transform One Shot Electrocompetent cells. Transformants were selected for by growing at 32°C on LB agar with carbenicillin (0.1 mg/mL). pGRG36-STM0233 and pGRG36-chiA were isolated using the Plasmid Midi kit (Qiagen), and Sanger sequencing was performed to confirm that the cloned chitinase genes had the correct sequence. Sanger sequencing was performed by the Genome Research core at the University of Illinois Chicago. The chitinase deletion strains (BL114, BL122, and BL130) were transformed with pGRG36-STM0233 or pGRG36-chiA. Transformants were isolated and grown in an LB culture at 32°C overnight. Overnight cultures were serially diluted in PBS and plated for single colonies on LB agar plates. Plates were incubated at 42°C overnight to block plasmid replication (pGRG36 has a temperature-sensitive origin of replication). Single colonies were streaked on LB agar and incubated at 42°C overnight to ensure plasmid loss. Insertion of the chitinase genes in the Tn7 locus was confirmed by colony PCR. The presence of STM0233 was detected with the primer pair STM0233_pres_Fw and STM0233_pres_Rv, and chiA was detected with the primer pair chiA_pres_Fw and chiA_pres_Rv. A primer set that flanks the Tn7 insertion site (Tn7_ck_FW and Tn7_ck_RV) was used to confirm the insertion site.

Tissue culture

The T84 colonic epithelial cell line (ATCC Cat# CCL-248; RRID:CVCL_0555) and IPEC-1 small intestinal epithelial cell line (DSMZ Cat# ACC-705, RRID:CVCL_2245) were grown in T75 flasks using 20 mL DMEM/F12 + 10% FBS + 1x antibiotic/antimycotic (Gibco). Cultures were incubated at 37°C with 5% CO2. Media was replaced every other day. Cell cultures were split with 0.25% trypsin + EDTA (Gibco) when cells reached 80% confluency.

Invasion assay

T84 or IPEC-1 cells were seeded onto a 24-well plate at a density of 5x105 cells/well with media lacking antibiotics/antimycotics and incubated overnight at 37°C. S. Typhimurium strains were grown for 16 h in liquid LB without shaking at 37°C. Bacterial cell number was quantified by measuring the OD600 of the cultures. 1x109 cells of each strain were centrifuged, resuspended in DMEM/F12, and serially diluted. Epithelial cells were infected with 5x105 cells of S. Typhimurium (multiplicity of infection (MOI) = 1). Infected cells were incubated at 37°C for 1 h. The inoculum was serially diluted and plated on LB agar to confirm bacterial numbers. After infection, the media was removed via vacuum, and wells were washed 3 times with 500 μL phosphate-buffered saline (PBS). 500 μL of DMEM/F12 + 10% FBS + 0.1 mg/mL gentamicin was added to the wells and incubated at 37°C for 1 h to kill extracellular bacteria. After incubation, the wells were washed with PBS and lysed by incubation with 1% Triton X-100 for 5 mins. Cells were disrupted and harvested by scraping wells and pipetting, were serially diluted, and plated on LB agar to quantify bacterial cells that invaded. The percentage of cells recovered relative to the inoculum was calculated.

Adhesion assay

This assay was adapted from a previous study [55]. T84 cells were seeded onto a 24-well plate at a density of 2x106 cells/well to achieve confluency and prevent nonspecific binding of S. Typhimurium to the bottom of the well. IPEC-1 cells were seeded at a density of 5x105 cells/well, which was sufficient to achieve confluency. The media used lacked antibiotics/antimycotics, and the cells were incubated overnight at 37°C. S. Typhimurium strains were grown in liquid LB without shaking for 16 h at 37°C. T84 and IPEC-1 cells were incubated in DMEM/F12 + 10% FBS + 2 μg/ml Cytochalasin D (Sigma-Aldrich) at 37°C for 1 h to block actin-dependent invasion. The OD600 was measured for each S. Typhimurium culture, and 1x109 cells of each strain were centrifuged, resuspended in DMEM/F12, and serially diluted. While in the presence of Cytochalasin D, epithelial cells were infected at a MOI = 1. Infection was carried out for 30 minutes, and epithelial cells were washed 4 times with PBS and lysed with 1 mL 1% Triton X-100. Cells were disrupted and harvested by scraping wells and pipetting, serially diluted, and plated on LB agar to quantify adherent bacterial cells. The percentage of cells recovered relative to the inoculum was calculated.

In vitro growth curve

Colloidal chitin was made based on a previous study [56]. Crab shell flakes were ground by mortar and pestle and sieved through a 130 mm two-piece polypropylene Büchner filter. 20 g of sieved crab shell flakes were placed in a beaker, and 150 mL of 12 M HCl was added slowly with continuous stirring. The chitin-HCl mixture was stirred every 5 min over the course of an hour. The mixture was then passed through 8 layers of cheesecloth to remove large chunks into a 2 L plastic beaker. 2 L of ice-cold MilliQ water was added and incubated at 4°C for 16 h. After incubation, 3 L of tap water was passed through the colloidal chitin cake on two layers of coffee filter paper in a Büchner funnel connected to a vacuum filtration flask until the pH of the filtrate was 7.0. Excess moisture was removed by pressing the colloidal chitin cake between coffee filter paper. The colloidal chitin cake was sterilized in an autoclave and used to make M9 + 0.4% colloidal chitin medium (M9 + chitin). The bacterial concentrations of 16 h S. Typhimurium cultures grown in LB were determined by measuring OD600. 20 mL of LB or M9 + chitin was inoculated with 1 x 105 cells of S. Typhimurium. Cultures were incubated shaking at 37°C, and samples were taken at indicated time points, serially diluted in PBS, and plated on LB agar.

Mouse infection

A streptomycin-pretreatment mouse model was used for the in vivo infections [33], where each mouse is considered an experimental unit. Single infection experiments were repeated twice with 3–5 mice per treatment group. 8 week-old female C57BL/6 mice were purchased from a maximum barrier facility at Jackson Laboratory and were free of Enterobacteriaceae (tested by plating fecal samples on MacConkey agar). Mice were housed for 1 week after arrival to allow for their acclimation and given water and food ad libitum (mice were fed Teklad Irradiated LM-485 mouse diet 7912). Mice were treated with 100 μL of 200 mg/mL streptomycin (Calbiochem) in water by oral gavage. 24 h after treatment, mice were infected by oral gavage with 100 μL of 1x1010 cells/mL of S. Typhimurium in LB broth from a 16 h culture. For co-infections, mice were infected with a 1:1 ratio of both S. Typhimurium strains. The S. Typhimurium strains used carry plasmid pHP45Ω, which confers resistance to streptomycin and carbenicillin. Fecal samples were collected at 8 hpi and 24 hpi and either snap-frozen or plated on LB agar + carbenicillin (0.1 mg/mL). At 48 hpi (or 96 hpi), mice were euthanized by CO2 asphyxiation and subsequent cervical dislocation. Immediately after euthanasia, the Peyer’s patches, mesenteric lymph nodes, spleen, liver, and luminal samples from the colon and ileum were collected, homogenized, and plated on LB agar with the appropriate antibiotic. Colony-forming units were normalized to the weight of each sample (mg). Cecum, ileum, and luminal colon samples were snap-frozen. Ileum and cecum samples were collected and fixed in formalin for histological analysis. Tissue was collected from the terminal ileum and proximal colon, and a gentamicin protection assay was performed. The tissue was incubated in PBS + 0.1 mg/mL gentamicin for 30 mins, washed with PBS, homogenized, and plated on LB agar + carbenicillin (0.1 mg/mL). For co-infection, the mutant strain was quantified by plating on LB agar + chloramphenicol (0.03 mg/mL). WT colonization was calculated by subtracting the mutant CFUs from the CFUs appearing on LB agar + carbenicillin. A competitive index was calculated by dividing CFU/mg of recovered WT by CFU/mg of recovered mutant. This competitive index was corrected based on the ratio of each strain in the inoculum, determined by serial dilution followed by plating on LB agar. Corrected CI = (WT colonization/mutant colonization)/ (WT inoculum/mutant inoculum).

For intraperitoneal infection, 9 week-old female C57BL/6 mice were infected via intraperitoneal injection with 100 μL of 1x105 cells/ml of S. Typhimurium in PBS from a 16 h culture. Mice were sacrificed at 24 hpi or 48 hpi, and the spleen and liver were collected. Samples were homogenized and plated on LB agar and the appropriate antibiotic to quantify colonization.

Histopathology

Tissue sections were fixed with formalin and embedded in paraffin wax. Embedding was done by the Research Histology core at the University of Illinois Chicago. The tissue was then sectioned via microtome and transferred to slides. Before staining, deparaffinization was performed. The tissue slides were immersed in xylene for 10 min, 100% ethanol for 10 min, 90% ethanol for 2 min, 70% ethanol for 2 min, and PBS for 5 min. The tissue slides were then stained with hematoxylin for 30 seconds, washed with tap water, then stained with eosin for 10 min. Slides were dehydrated by immersion in serial increases of ethanol concentrations (50%-100%), then immersed in xylene. Coverslips were then mounted to the tissue slides and allowed to dry.

Tissue sections were scored for pathology by a board-certified pathologist in a blinded fashion following an approach established by Barthel and colleagues [33] as summarized below.

Submucosal edema was scored as follows: 0 = no pathological changes; 1 = mild edema (submucosa accounts for <50% of the diameter of the entire intestinal wall [tunica muscularis to epithelium]); 2 = moderate edema; the submucosa accounts for 50 to 80% of the diameter of the entire intestinal wall; and 3 = profound edema (the submucosa accounts for >80% of the diameter of the entire intestinal wall).

Polymorphonuclear granulocytes (PMN) in the lamina propria were enumerated in 10 high-power fields (x400 magnification), and the average number of PMN/high-power fields was calculated. The scores were defined as follows: 0 = <5 PMN/high-power field; 1 = 5 to 20 PMN/high-power field; 2 = 21 to 60/high-power field; 3 = 61 to 100/high-power field; and 4 = >100/high-power field. Transmigration of PMN into the intestinal lumen was consistently observed when the number of PMN was >60 PMN/high-power field.

The average number of goblet cells per high-power field (magnification, x400) was determined from 10 different regions of the cecal epithelium. Scoring was as follows: 0 = >28 goblet cells/high-power field (magnification, x400); 1 = 11 to 28 goblet cells/high-power field; 2 = 1 to 10 goblet cells/high-power field; and 3 = <1 goblet cell/high-power field.

Epithelial integrity was scored as follows: 0 = no pathological changes detectable in 10 high-power fields (x400 magnification); 1 = epithelial desquamation; 2 = erosion of the epithelial surface (gaps of 1 to 10 epithelial cells/lesion); and 3 = epithelial ulceration (gaps of >10 epithelial cells/lesion).

Two independent scores for submucosal edema, PMN infiltration, goblet cells, and epithelial integrity were averaged for each tissue sample. The combined pathological score for each tissue sample was determined as the sum of these averaged scores. It ranges between 0 and 13 arbitrary units and covers the following levels of inflammation: 0 intestine intact without any signs of inflammation; 1 to 2 minimal signs of inflammation; 3 to 4 slight inflammation; 5 to 8 moderate inflammation; and 9 to 13 profound inflammation.

RNA extraction

In vivo: Cecum and ileum samples collected from mice 48 hpi were homogenized by mortar and pestle and liquid nitrogen. Because mice were treated with streptomycin 24 h prior to infection, we collected cecum and ileum samples from uninfected mice 72 h after streptomycin treatment as a control. The homogenate was transferred to 1 mL of Tri-Reagent (Molecular Research Center) for RNA extraction. RNA was extracted with 0.1 mL of bromo-3-chloropropane, centrifuged, and the upper phase was precipitated with 0.5 mL isopropanol. After centrifugation, pellets were washed twice with 1 mL of 75% ethanol in RNase-free water. The RNA pellet was then resuspended in RNase-free water. RNA was treated with DNase using the Turbo DNA-free kit (Invitrogen). For fecal samples, RNA was extracted from snap-frozen luminal colon samples collected during the single infection mouse experiments. RNA extraction was performed using the Qiagen RNeasy PowerMicrobiome kit, and DNase treatment was performed with the Turbo DNA-free kit.

In vitro: A 16 h culture of WT S. Typhimurium was sub-cultured (1:100) into LB or DMEM/12 +10% FBS. Cultures were incubated for 3 h at 37°C, shaking at 200 rpm. Culture cell concentration was measured by OD600, and 1x109 cells were pelleted by centrifugation. RNA extraction was performed on the pellet using the Invitrogen RiboPure Bacteria kit. RNA extraction was followed by DNase treatment using the Turbo DNA-free kit.

RT-qPCR

Reverse transcription was performed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). For S. Typhimurium RNA, reactions were also performed without the addition of reverse transcriptase to confirm that there was no amplification of DNA in qPCR reactions. 1000 ng of RNA was used for the reverse transcription reaction. The reverse transcription cycle consisted of 10 minutes at 25°C followed by 120 minutes at 37°C and 5 minutes at 85°C. qPCR was performed using the Fast SYBR Green Master Mix (Applied Biosystems) on the Viia7 Real-time PCR system at the Genome Research core at the University of Illinois at Chicago. The qPCR reaction cycle consisted of 20 seconds at 95°C followed by 40 cycles of 3 seconds at 95°C and 30 seconds at 60°C. Reactions were performed in duplicate. Relative expression was calculated based on the ΔCT values. For the analysis of chitinase expression, the CT value of the house-keeping gene (gmk), which has been shown to be stably expressed across a variety of conditions [57], was subtracted from the CT value of the gene of interest, giving the ΔCT value. Relative expression = 2(-ΔCT). In vivo chitinase gene expression was compared to expression in LB broth by subtracting the ΔCT value of LB broth from the ΔCT of fecal samples. Relative expression = 2(-ΔΔCT). For analysis of murine immune gene expression, the CT value of the housekeeping gene (actb) was subtracted from the CT value of the gene of interest, giving the ΔCT value. The ΔCT value of uninfected mice was subtracted from the ΔCT value of infected mice, giving the ΔΔCT value. Relative expression = 2(-ΔΔCT) (S3 Table).

Glycome analysis

Infection of IPEC-1 cells was carried out similar to the invasion assays at an MOI of 1:1000. Two biological replicates with three technical replicates each were used for each infected sample. Biological replicates consisted of culturing and seeding IPEC-1 cells independently of each other. Uninfected samples also consisted of two independently cultured biological replicates, with 7 technical replicates for each. After infection, wells were washed twice with PBS, and cells were frozen at -80°C. Cells were thawed and washed twice with PBS to remove the lysed cell debris and cytoplasmic proteins. Next, 200 μL PBS and 3 μL PNGase F were added to each well and incubated at 37°C for 18 hrs to release surface N-glycans. A sealing film (Axygen PCRSPS) was employed to cover the well plate to prevent evaporation. The released N-glycans solution was collected, and the well was washed with 200 μL PBS. The wash solution was collected and combined with the previously released N-glycan solution, dried, and redissolved in 100 μL water. N-glycans were then dialyzed against a 500–1000 MWCO dialysis membrane to remove salts and small molecules. The dialyzed sample was then reduced and permethylated prior to LC-MS/MS analysis, as previously reported [5860]. Briefly, the dried sample was dissolved in 10 μL borane-ammonia complex solution (10 mg/mL) and incubated in a 60°C water bath for 1h. After reduction, 1 mL of methanol was added to each sample and dried. The methanol addition-dry cycle was repeated 3 times to remove borates. Next, a spin column was packed with sodium hydroxyl beads (suspended in DMSO) and washed twice with 200 μL DMSO. Reduced glycans were resuspended in 30 μL DMSO, 1.2 μL water, and 20 μL iodomethane. The sample was loaded on the column and incubated for 25 min. Then, 20 μL iodomethane was added to each column and incubated for 15 min. After incubation, permethylated glycan solution was collected by centrifuging at 1,800 rpm. The column was then washed with 30 μL acetonitrile (ACN), and the ACN solution was combined with permethylated glycan solution and dried. The reduced and permethylated sample was ready for LC-MS/MS analysis.

Samples were analyzed using an UltiMate 3000 nanoLC system coupled to an LTQ Orbitrap Velos mass spectrometer. The samples were resuspended in 8 μL solution (20% ACN, 80% water, 0.1% formic acid) and injected 6 μL. A PepMap trap column (75 μm* 2 cm, C18, 3 μm, Thermo) was used for online purification. The N-glycomic analysis was performed on a PepMap column (75 μm * 15 cm, C18, 2 μm, Thermo) at 55°C at 0.35 μL/min flow rate. A gradient of mobile phase solvents A (98% water with 0.1% FA) and B (98% ACN with 0.1% FA) was used as follows: 0–10 min, 20% B; 10–11 min, 20% - 42% B; 11–48 min, 42% - 55% B; 48–49 min, 55% - 90% B; 49–54 min, 90% B; 54–55 min, 90% - 20% B; 55–60 min, 20% B. The MS was performed in positive mode. The full MS scan had a range of 700−2000 m/z at a mass resolution of 100,000. The CID (collision-induced dissociation) was used for MS2 at a normalized collision energy of 35, activation Q of 0.25, and activation time of 10 ms. The data were first processed by MultiGlycan software [61], then manually checked via full MS and MS2 to remove false positives. N-glycan biosynthesis is performed by a series of glycosidases and glycosyltransferases, and monosaccharides are sequentially added through the action of specific transferases [62]. Therefore, the assignment of putative N-glycan structures can be achieved through matching full MS to N-glycan compositions followed by the structural confirmation via MS2, as the examples shown in (S8 Fig).

Statistical analysis

Statistical analysis was performed with Graphpad Prism software v9 (RRID:SCR_002798). Data were tested for normality using the Shapiro-Wilk test and confirmed visually via QQ plot. For data found to follow a lognormal distribution, data were transformed to their natural log values before analysis. Unless otherwise specified, all multiple comparison analyses compared samples to the WT control. For invasion assays, the percent recovery was analyzed with a one-way ANOVA with Dunnett’s multiple comparison test. For adhesion assays, the percent recovery was analyzed with a mixed-effect analysis with Dunnett’s multiple comparison test. For mouse single infection experiments, a one-way ANOVA with Dunnett’s multiple comparison test (Intragastric) or an unpaired t-test was performed (Intraperitoneal). For mouse co-infection experiments, a paired t-test was performed with the absolute values, and the competitive index was analyzed with a one-sample t-test against our null hypothesis that the competitive index equaled one. For in vitro chitinase gene expression analysis, an unpaired t-test was performed. In vivo relative expression of chitinase expression was analyzed with a one-sample t-test against our null hypothesis (relative expression = 1). For murine gene expression, a one-way ANOVA with Dunnett’s multiple comparison test was performed. Analysis of growth curves was done with a mixed-effect analysis and Tukey’s multiple comparisons test. For the glycome analysis, the relative abundance for each glycan was calculated by dividing the individual glycan abundance by the total glycan abundance. A Mann-Whitney U test was then performed comparing samples to WT or uninfected. The relative abundance of Lewis X/A structures was calculated by dividing the total number of glycans that contain these structures by the total glycan abundance of each sample. A one-way ANOVA with Dunnett’s multiple comparison test was then performed. For all statistical tests, significance was set at α = 0.05.

Supporting information

S1 Fig. Deletion of S. Typhimurium chitinases does not affect growth characteristics.

(A) Growth of S. Typhimurium strains in LB broth at 37°C. WT n = 5, chitinase-deficient strains n = 3. Points represent geometric mean ± geometric SD. (B) Growth of S. Typhimurium strains in M9 minimal medium +0.4% colloidal chitin at 37°C. n = 3. Points represent geometric mean ± geometric SD. Statistics: Mixed-effect analysis and Tukey’s multiple comparisons test.

(TIFF)

S2 Fig. Complementation of chitinase-deficient strains restores invasion.

Chitinase genes were inserted into the Tn7 locus of chitinase-deficient S. Typhimurium. Gentamicin protection assay of S. Typhimurium infected (MOI:1) small intestinal epithelial cells (IPEC-1). (A) Invasion of ΔchiA and chiA complemented strain. n = 8. (B) Invasion of ΔSTM0233 and STM0233 complemented strain. n = 8. (C) Invasion of ΔSTM0233 ΔchiA (Δ2) and Δ2 strain complemented with chiA or STM0233. n = 6. Percent recovery of each strain was normalized to WT recovery. Bars represent mean ± SEM. Statistics: One-way ANOVA with Dunnett’s multiple comparison test.

(TIFF)

S3 Fig. Cytochalasin D treatment completely blocks S. Typhimurium invasion.

(A) Gentamicin protection assay of S. Typhimurium infected (MOI:1) colonic epithelial cells (T84) after treatment of epithelial cells with cytochalasin D (1–2 μg/mL). (B) Gentamicin protection assay of S. Typhimurium infected (MOI:1) small intestinal epithelial cells (IPEC-1) after treatment of epithelial cells with cytochalasin D (2 μg/mL). n = 2. Bars represent mean ± SD.

(TIFF)

S4 Fig. S. Typhimurium chitinases are not required for late-stage infection.

(A) Streptomycin pre-treatment mouse model of 96 h S. Typhimurium infection. (B) Luminal samples from the terminal ileum were collected at 96 hpi to determine S. Typhimurium colonization. Invasion was determined with a gentamicin protection assay performed on the terminal ileum. WT n = 3, ΔSTM0233 n = 3, ΔchiA n = 4. (C) S. Typhimurium colonies recovered from fecal samples collected at 24, 48, and 72 hpi. Fecal samples at 96 hpi were collected directly from the lumen of the colon. Invasion of colonic tissue was determined with a gentamicin protection assay. WT n = 10, ΔSTM0233 n = 8, ΔchiA n = 8. (D) Colonization of the Peyer’s patches, mesenteric lymph nodes, spleen, and liver after 96 h of intragastric infection. WT n = 10, ΔSTM0233 n = 8, ΔchiA n = 8. Bars represent geometric mean ± geometric SD. Statistics: (B-D) Stars indicate significance compared to the WT control by one-way ANOVA with Dunnett’s multiple comparison test. * = p<0.05.

(TIFF)

S5 Fig. Representative images of cecum and ileum histology.

Uninfected: (A) & (B) Cecum–intestine intact without any signs of inflammation [A: low power, hematoxylin eosin, original magnification 40x; B: intermediate power, hematoxylin-eosin, original magnification 200x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin eosin, original magnification 40x; D: intermediate power, hematoxylin eosin, original magnification 200x]. WT: (A) & (B) Cecum–moderate inflammation (moderate submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: high power, hematoxylin-eosin, original magnification 400x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x]. ΔSTM0233: (A) & (B) Cecum–moderate inflammation (moderate submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: intermediate power, hematoxylin-eosin, original magnification 200x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x]. ΔchiA: (A) & (B) Cecum–moderate inflammation (profound submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: intermediate power, hematoxylin-eosin, original magnification 200x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x]. ΔSTM0233 ΔchiA: (A) & (B) Cecum–moderate inflammation (moderate submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: high power, hematoxylin- eosin, original magnification 400x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x].

(TIFF)

S6 Fig. Innate immune gene expression in infected ileal tissue.

(A-E) mRNA expression of innate immune genes extracted from ileal tissue of S. Typhimurium infected mice 48 hpi. Expression is normalized to the housekeeping gene actb as well as gene expression in uninfected mice. n = 8 per group. Bars represent geometric mean ± geometric SD. There was no statistical significance (α = 0.05) comparing groups to the WT control by one-way ANOVA with Dunnett’s multiple comparison test.

(TIFF)

S7 Fig. Chitinase-deficient strains maintained invasion defects for glycome analysis.

Gentamicin protection assay of S. Typhimurium infected IPEC-1 cells (MOI:1000) done concurrently with infection for the glycome analysis. n = 2. Bars represent mean ± SD.

(TIFF)

S8 Fig. N-linked glycan identification using MS data.

Examples of (A) complex and (B) high-mannose N-glycan identification through full MS and MS2. Insets are full MS spectra showing isotopic distribution envelops. The N-glycan compositions are identified through full MS within an m/z accuracy of 10 ppm. The putative N-glycan structures are further confirmed by matching the fragment ions detected in MS2 spectra.

(TIFF)

S1 Table. Bacterial strains and plasmids used.

(XLSX)

S2 Table. Primers used for cloning.

(XLSX)

S3 Table. Primers used for RT-qPCR.

(XLSX)

S4 Table. Relative abundance of all glycan species identified in glycome analysis.

Average relative abundance of glycan species after infecting IPEC-1 cells with S. Typhimurium for 1 h (MOI:1000). Uninfected n = 14, WT n = 6, ΔSTM0233 n = 6, ΔchiA n = 6, ΔSTM0233 ΔchiA n = 6. Relative abundance is calculated by dividing glycan species abundance by total glycan abundance. Raw data has been uploaded to GlycoPOST database [63], accession number GPST000225.

(XLSX)

S1 Data. Numerical data used for statistical analysis.

Excel sheet containing the numerical data for Figs 1A–1E, 2B–2D, 3A and 3B, 4A–4M, 5A–5C, 6F, S1A and S1B, S2A–S2C, S3A and S3B, S4B–S4D, S6A–S6E, and S7.

(XLSX)

Acknowledgments

We thank Clayton Wollner and Kristen Lednovich for technical assistance in initial experiments. We thank Dara Kiani, Amisha Rana, Kelly Perfecto, Kanchan Jaswal, and Olivia Todd for their careful review of this manuscript. The model was created using biorender.com.

Data Availability

Glycome analysis data set is available in the GlycoPOST repository via the accession number GPST000225. All other relevant data is present within this manuscript.

Funding Statement

This work was supported by the National Institutes of Health (1R01AI143641 to JB and 1R01GM112490 to YM) and the Department of Microbiology at the University of Illinois Chicago (to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Zhang S, Kingsley RA, Santos RL, Andrews-Polymenis H, Raffatellu M, Figueiredo J, et al. Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea. Infect Immun. 2003;71: 1–12. doi: 10.1128/IAI.71.1.1-12.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Knodler LA, Vallance BA, Celli J, Winfree S, Hansen B, Montero M, et al. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc Natl Acad Sci U S A. 2010;107: 17733–17738. doi: 10.1073/pnas.1006098107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gordon MA. Salmonella infections in immunocompromised adults. J Infect. 2008;56: 413–422. doi: 10.1016/j.jinf.2008.03.012 [DOI] [PubMed] [Google Scholar]
  • 4.López FE, de las Mercedes Pescaretti M, Morero R, Delgado MA. Salmonella Typhimurium general virulence factors: A battle of David against Goliath? Food Res Int. 2012;45: 842–851. doi: 10.1016/j.foodres.2011.08.009 [DOI] [Google Scholar]
  • 5.Ibarra JA, Steele-Mortimer O. Salmonella—the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol. 2009;11: 1579–1586. doi: 10.1111/j.1462-5822.2009.01368.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Broz P, Ohlson MB, Monack DM. Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes. 2012;3: 62–70. doi: 10.4161/gmic.19141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Arabyan N, Huang BC, Weimer BC. Draft Genome Sequences of Salmonella enterica Serovar Typhimurium LT2 with Deleted Chitinases That Are Emerging Virulence Factors. Genome Announc. 2017;5. doi: 10.1128/genomeA.00659-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hamid R, Khan MA, Ahmad M, Ahmad MM, Abdin MZ, Musarrat J, et al. Chitinases: An update. J Pharm Bioallied Sci. 2013;5: 21–29. doi: 10.4103/0975-7406.106559 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bokma E, van Koningsveld GA, Jeronimus-Stratingh M, Beintema JJ. Hevamine, a chitinase from the rubber treeHevea brasiliensis, cleaves peptidoglycan between the C-1 ofN-acetylglucosamine and C-4 ofN-acetylmuramic acid and therefore is not a lysozyme. FEBS Letters. 1997. pp. 161–163. doi: 10.1016/s0014-5793(97)00682-0 [DOI] [PubMed] [Google Scholar]
  • 10.Rehman S, Grigoryeva LS, Richardson KH, Corsini P, White RC, Shaw R, et al. Structure and functional analysis of the Legionella pneumophila chitinase ChiA reveals a novel mechanism of metal-dependent mucin degradation. PLoS Pathog. 2020;16: e1008342. doi: 10.1371/journal.ppat.1008342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.DebRoy S, Dao J, Söderberg M, Rossier O, Cianciotto NP. Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung. Proc Natl Acad Sci U S A. 2006;103: 19146–19151. doi: 10.1073/pnas.0608279103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chaudhuri S, Gantner BN, Ye RD, Cianciotto NP, Freitag NE. The Listeria monocytogenes ChiA chitinase enhances virulence through suppression of host innate immunity. MBio. 2013;4: e00617–12. doi: 10.1128/mBio.00617-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chaudhuri S, Bruno JC, Alonzo F, Xayarath B, Cianciotto NP, Freitag NE. Contribution of Chitinases to Listeria monocytogenes Pathogenesis. Applied and Environmental Microbiology. 2010. pp. 7302–7305. doi: 10.1128/AEM.01338-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mondal M, Nag D, Koley H, Saha DR, Chatterjee NS. The Vibrio cholerae extracellular chitinase ChiA2 is important for survival and pathogenesis in the host intestine. PLoS One. 2014;9: e103119. doi: 10.1371/journal.pone.0103119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bhowmick R, Ghosal A, Das B, Koley H, Saha DR, Ganguly S, et al. Intestinal adherence of Vibrio cholerae involves a coordinated interaction between colonization factor GbpA and mucin. Infect Immun. 2008;76: 4968–4977. doi: 10.1128/IAI.01615-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Low D, Tran HT, Lee I-A, Dreux N, Kamba A, Reinecker H-C, et al. Chitin-binding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis. Gastroenterology. 2013;145: 602–12.e9. doi: 10.1053/j.gastro.2013.05.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kawada M, Chen C-C, Arihiro A, Nagatani K, Watanabe T, Mizoguchi E. Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein. Laboratory Investigation. 2008. pp. 883–895. doi: 10.1038/labinvest.2008.47 [DOI] [PubMed] [Google Scholar]
  • 18.Mizoguchi E. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology. 2006;130: 398–411. doi: 10.1053/j.gastro.2005.12.007 [DOI] [PubMed] [Google Scholar]
  • 19.Hautefort I, Thompson A, Eriksson-Ygberg S, Parker ML, Lucchini S, Danino V, et al. During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems. Cell Microbiol. 2008;10: 958–984. doi: 10.1111/j.1462-5822.2007.01099.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Eriksson S, Lucchini S, Thompson A, Rhen M, Hinton JCD. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol Microbiol. 2003;47: 103–118. doi: 10.1046/j.1365-2958.2003.03313.x [DOI] [PubMed] [Google Scholar]
  • 21.Harvey PC, Watson M, Hulme S, Jones MA, Lovell M, Berchieri A Jr, et al. Salmonella enterica serovar typhimurium colonizing the lumen of the chicken intestine grows slowly and upregulates a unique set of virulence and metabolism genes. Infect Immun. 2011;79: 4105–4121. doi: 10.1128/IAI.01390-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Larsen T, Petersen BO, Storgaard BG, Duus JØ, Palcic MM, Leisner JJ. Characterization of a novel Salmonella Typhimurium chitinase which hydrolyzes chitin, chitooligosaccharides and an N-acetyllactosamine conjugate. Glycobiology. 2011;21: 426–436. doi: 10.1093/glycob/cwq174 [DOI] [PubMed] [Google Scholar]
  • 23.Frederiksen RF, Yoshimura Y, Storgaard BG, Paspaliari DK, Petersen BO, Chen K, et al. A Diverse Range of Bacterial and Eukaryotic Chitinases Hydrolyzes the LacNAc (Galβ1–4GlcNAc) and LacdiNAc (GalNAcβ1–4GlcNAc) Motifs Found on Vertebrate and Insect Cells. Journal of Biological Chemistry. 2015. pp. 5354–5366. doi: 10.1074/jbc.m114.607291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kavanaugh D, O’Callaghan J, Kilcoyne M, Kane M, Joshi L, Hickey RM. The intestinal glycome and its modulation by diet and nutrition. Nutr Rev. 2015;73: 359–375. doi: 10.1093/nutrit/nuu019 [DOI] [PubMed] [Google Scholar]
  • 25.Arabyan N, Park D, Foutouhi S, Weis AM, Huang BC, Williams CC, et al. Salmonella Degrades the Host Glycocalyx Leading to Altered Infection and Glycan Remodeling. Scientific Reports. 2016. doi: 10.1038/srep29525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Park D, Arabyan N, Williams CC, Song T, Mitra A, Weimer BC, et al. Salmonella typhimurium enzymatically landscapes the host intestinal epithelial cell (IEC) surface glycome to increase invasion. Mol Cell Proteomics. 2016;15: 3653–3664. doi: 10.1074/mcp.M116.063206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Thankavel K, Shah AH, Cohen MS, Ikeda T, Lorenz RG, Curtiss R 3rd, et al. Molecular basis for the enterocyte tropism exhibited by Salmonella typhimurium type 1 fimbriae. J Biol Chem. 1999;274: 5797–5809. doi: 10.1074/jbc.274.9.5797 [DOI] [PubMed] [Google Scholar]
  • 28.Galán JE, Curtiss R 3rd. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci U S A. 1989;86: 6383–6387. doi: 10.1073/pnas.86.16.6383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lou L, Zhang P, Piao R, Wang Y. Salmonella Pathogenicity Island 1 (SPI-1) and Its Complex Regulatory Network. Front Cell Infect Microbiol. 2019;9: 270. doi: 10.3389/fcimb.2019.00270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wagner C, Hensel M. Adhesive mechanisms of Salmonella enterica. Adv Exp Med Biol. 2011;715: 17–34. doi: 10.1007/978-94-007-0940-9_2 [DOI] [PubMed] [Google Scholar]
  • 31.Lara-Tejero M, Galán JE. Salmonella enterica serovar typhimurium pathogenicity island 1-encoded type III secretion system translocases mediate intimate attachment to nonphagocytic cells. Infect Immun. 2009;77: 2635–2642. doi: 10.1128/IAI.00077-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Misselwitz B, Kreibich SK, Rout S, Stecher B, Periaswamy B, Hardt W-D. Salmonella enterica serovar Typhimurium binds to HeLa cells via Fim-mediated reversible adhesion and irreversible type three secretion system 1-mediated docking. Infect Immun. 2011;79: 330–341. doi: 10.1128/IAI.00581-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Barthel M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M, Hogardt M, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71: 2839–2858. doi: 10.1128/IAI.71.5.2839-2858.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Jepson MA, Clark MA. The role of M cells in Salmonella infection. Microbes Infect. 2001;3: 1183–1190. doi: 10.1016/s1286-4579(01)01478-2 [DOI] [PubMed] [Google Scholar]
  • 35.Watson KG, Holden DW. Dynamics of growth and dissemination of Salmonella in vivo. Cell Microbiol. 2010;12: 1389–1397. doi: 10.1111/j.1462-5822.2010.01511.x [DOI] [PubMed] [Google Scholar]
  • 36.Hurley D, McCusker MP, Fanning S, Martins M. Salmonella-host interactions—modulation of the host innate immune system. Front Immunol. 2014;5: 481. doi: 10.3389/fimmu.2014.00481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Almagro Armenteros JJ, Tsirigos KD, Sønderby CK, Petersen TN, Winther O, Brunak S, et al. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat Biotechnol. 2019;37: 420–423. doi: 10.1038/s41587-019-0036-z [DOI] [PubMed] [Google Scholar]
  • 38.Bendtsen JD, Kiemer L, Fausbøll A, Brunak S. Non-classical protein secretion in bacteria. BMC Microbiol. 2005;5: 58. doi: 10.1186/1471-2180-5-58 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Tran HT, Barnich N, Mizoguchi E. Potential role of chitinases and chitin-binding proteins in host-microbial interactions during the development of intestinal inflammation. Histol Histopathol. 2011;26: 1453–1464. doi: 10.14670/HH-26.1453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Frederiksen RF, Leisner JJ. Effects of Listeria monocytogenes EGD-e and Salmonella enterica ser. Typhimurium LT2 chitinases on intracellular survival in Dictyostelium discoideum and mammalian cell lines. FEMS Microbiol Lett. 2015;362. doi: 10.1093/femsle/fnv067 [DOI] [PubMed] [Google Scholar]
  • 41.Kirn TJ, Jude BA, Taylor RK. A colonization factor links Vibrio cholerae environmental survival and human infection. Nature. 2005;438: 863–866. doi: 10.1038/nature04249 [DOI] [PubMed] [Google Scholar]
  • 42.Bäumler AJ, Tsolis RM, Heffron F. Contribution of fimbrial operons to attachment to and invasion of epithelial cell lines by Salmonella typhimurium. Infect Immun. 1996;64: 1862–1865. doi: 10.1128/iai.64.5.1862-1865.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bäumler AJ, Tsolis RM, Bowe FA, Kusters JG, Hoffmann S, Heffron F. The pef fimbrial operon of Salmonella typhimurium mediates adhesion to murine small intestine and is necessary for fluid accumulation in the infant mouse. Infect Immun. 1996;64: 61–68. doi: 10.1128/iai.64.1.61-68.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Costa J, Ahluwalia A. Advances and Current Challenges in Intestinal Model Engineering: A Digest. Front Bioeng Biotechnol. 2019;7: 144. doi: 10.3389/fbioe.2019.00144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sonnenburg JL, Xu J, Leip DD, Chen C-H, Westover BP, Weatherford J, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 2005;307: 1955–1959. doi: 10.1126/science.1109051 [DOI] [PubMed] [Google Scholar]
  • 46.Pickard JM, Maurice CF, Kinnebrew MA, Abt MC, Schenten D, Golovkina TV, et al. Rapid fucosylation of intestinal epithelium sustains host–commensal symbiosis in sickness. Nature. 2014;514: 638–641. doi: 10.1038/nature13823 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Renkema GH, Herma Renkema G, Boot RG, Au FL, Donker-Koopman WE, Strijland A, et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. European Journal of Biochemistry. 1998. pp. 504–509. doi: 10.1046/j.1432-1327.1998.2510504.x [DOI] [PubMed] [Google Scholar]
  • 48.Aomatsu T, Imaeda H, Matsumoto K, Kimura E, Yoden A, Tamai H, et al. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2011. pp. 941–948. doi: 10.1111/j.1365-2036.2011.04805.x [DOI] [PubMed] [Google Scholar]
  • 49.Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, et al. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2016;43: 1069–1079. doi: 10.1111/apt.13585 [DOI] [PubMed] [Google Scholar]
  • 50.Arabyan N, Weis AM, Huang BC, Weimer BC. Implication of Sialidases in Infection: Genome Release of Sialidase Knockout Strains from Serovar Typhimurium LT2. Genome Announc. 2017;5. doi: 10.1128/genomeA.00341-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Hase K, Kawano K, Nochi T, Pontes GS, Fukuda S, Ebisawa M, et al. Uptake through glycoprotein 2 of FimH bacteria by M cells initiates mucosal immune response. Nature. 2009. pp. 226–230. doi: 10.1038/nature08529 [DOI] [PubMed] [Google Scholar]
  • 52.Kolenda R, Burdukiewicz M, Schiebel J, Rödiger S, Sauer L, Szabo I, et al. Adhesion of Salmonella to Pancreatic Secretory Granule Membrane Major Glycoprotein GP2 of Human and Porcine Origin Depends on FimH Sequence Variation. Frontiers in Microbiology. 2018. doi: 10.3389/fmicb.2018.01905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Chessa D, Dorsey CW, Winter M, Baümler AJ. Binding specificity of Salmonella plasmid-encoded fimbriae assessed by glycomics. J Biol Chem. 2008;283: 8118–8124. doi: 10.1074/jbc.M710095200 [DOI] [PubMed] [Google Scholar]
  • 54.McKenzie GJ, Craig NL. Fast, easy and efficient: site-specific insertion of transgenes into enterobacterial chromosomes using Tn7 without need for selection of the insertion event. BMC Microbiol. 2006;6: 39. doi: 10.1186/1471-2180-6-39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Elhadad D, Desai P, Grassl GA, McClelland M, Rahav G, Gal-Mor O. Differences in Host Cell Invasion and Salmonella Pathogenicity Island 1 Expression between Salmonella enterica Serovar Paratyphi A and Nontyphoidal S. Typhimurium. Infection and Immunity. 2016. pp. 1150–1165. doi: 10.1128/IAI.01461-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Murthy N, Bleakley B. Simplified method of preparing colloidal chitin used for screening of chitinase-producing microorganisms. Internet J Microbiol. 2012;10: e2bc3. Available: https://print.ispub.com/api/0/ispub-article/14186 [Google Scholar]
  • 57.Botteldoorn N, Van Coillie E, Grijspeerdt K, Werbrouck H, Haesebrouck F, Donné E, et al. Real-time reverse transcription PCR for the quantification of the mntH expression of Salmonella enterica as a function of growth phase and phagosome-like conditions. J Microbiol Methods. 2006;66: 125–135. doi: 10.1016/j.mimet.2005.11.003 [DOI] [PubMed] [Google Scholar]
  • 58.Dong X, Zhou S, Mechref Y. LC-MS/MS analysis of permethylated free oligosaccharides and N-glycans derived from human, bovine, and goat milk samples. Electrophoresis. 2016;37: 1532–1548. doi: 10.1002/elps.201500561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Gautam S, Peng W, Cho BG, Huang Y, Banazadeh A, Yu A, et al. Glucose unit index (GUI) of permethylated glycans for effective identification of glycans and glycan isomers. Analyst. 2020;145: 6656–6667. doi: 10.1039/d0an00314j [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Peng W, Goli M, Mirzaei P, Mechref Y. Revealing the Biological Attributes of N-Glycan Isomers in Breast Cancer Brain Metastasis Using Porous Graphitic Carbon (PGC) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). J Proteome Res. 2019;18: 3731–3740. doi: 10.1021/acs.jproteome.9b00429 [DOI] [PubMed] [Google Scholar]
  • 61.Yu C-Y, Mayampurath A, Hu Y, Zhou S, Mechref Y, Tang H. Automated annotation and quantification of glycans using liquid chromatography-mass spectrometry. Bioinformatics. 2013;29: 1706–1707. doi: 10.1093/bioinformatics/btt190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Varki A, Cummings RD, Esko JD, Hart GW. Essentials of Glycobiology. Cold Spring Harbor Laboratory Press; 2017. [PubMed] [Google Scholar]
  • 63.Watanabe Y, Aoki-Kinoshita KF, Ishihama Y, Okuda S. GlycoPOST realizes FAIR principles for glycomics mass spectrometry data. Nucleic Acids Res. 2021;49: D1523–D1528. doi: 10.1093/nar/gkaa1012 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Andreas J Baumler, Brian K Coombes

1 Feb 2022

Dear Dr. Behnsen,

Thank you very much for submitting your manuscript "Salmonella enterica serovar Typhimurium chitinases modulate the intestinal glycome and promote small intestinal invasion." for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Andreas J Baumler

Associate Editor

PLOS Pathogens

Brian Coombes

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: In this study, Devlin et al investigate the role of chitinase-like glycoside hydrolases in the pathogenesis of Salmonella infection. Defined mutants lacking activity of two chitinase-like glycoside hydrolases, either as single mutants or in combination, exhibit decreased invasiveness and adhesion towards culture epithelial cells (IPEC-1 and T84 cell lines). Chitinase-deficient mutants are less invasive (about one order of magnitude) in the small intestine in a mouse model of Salmonella-induced colitis. ChiA is also required for efficient dissemination to systemic sites, but is dispensable for systemic replication. The defect of chitinase-deficient mutants in the mouse model is rescued by co-infection with the wild type, consistent with the fact that these chitinases are secreted. Evidence is presented that the glycome of cultured epithelial cells is changed upon Salmonella infection, and that this change is in part dependent on chitinase activity.

The main finding that Salmonella uses glycoside hydrolases to promote early invasion events in the small intestine is intriguing and novel, and should be of high interest to the audience of Plos Pathogens. The manuscript is well written. The majority of the conclusions are justified.

Reviewer #2: Manuscript by Devlin et al investigates the role of two annotated chitinases STM0018 (chiA) and STM0233 during Salmonella infection and pathogenesis. While ChiA was studied before, STM0233s role has not been investigated prior to this study. Authors demonstrate that both chitinases are upregulated in the mouse gut and facilitate epithelial cell adhesion and invasion. While wild type Salmonella that produces the two chitinases can hydrolyze the N-acetylglucosamine-containing glycans in the mouse gut and on epithelial cells, promoting the adhesion of the pathogen, mutants defective in one or both chitinases show reduced adhesion, invasion and dissemination to systemic organs. Finally the authors investigate the glycan profiles in wild type and the mutant bacteria to show how these chitinases increase the exposure of certain glycans including LewisX glycans so that the wild type Salmonella can increase its binding and facilitate virulence. Overall this is a well-performed study that increases of our understanding of initial steps of Salmonella pathogenesis and how this pathogen can bind and invade epithelial tissue. Study is supported by both in vitro and in vivo mouse experiments. There are few minor concerns.

Reviewer #3: This work relies on previous publications describing that chitin-degrading enzymes participate in bacterial pathogenesis. In this work, the authors address the role of two chitinases, in the pathogenesis of Salmonella Typhimurium. The work shows that chitinase mutants exhibit reduced adhesion to cultured intestinal epithelial cells, reduced invasion in the ileum and lower dissemination into systemic organs, compared to the wt strain. Chitinases also cause significant change into the glycan repertoire on intestinal epithelial cells, although some changes cannot be attributed to the glycolytic activity of the enzymes, and the underlying mechanism remains elusive.

The manuscript is well-organizes and the writing is clear and focused. The topic is very important and timely, and holds a potentially significant contribution to the field of pathogenesis. The experiments are well-performed and the data is compelling. My main concern is that the molecular underpinnings are still very obscure and it remains unclear how does the enzymatic activity of chitinases executes all the observed phenotype. However, the findings in this work are novel and important, and will probably provide a solid base for further studies.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: I only have one concern regarding the interpretation of the glycomics data and the conclusion that “STM0233 and ChiA enhance Salmonella adhesion to epithelial cells likely due to the exposure of mannose and increase in Lewis X binding residues.” This conclusion is primarily based on the experiment shown in Fig. 6. In this experiment, the authors have shown that Salmonella induces changes in the surface glycome of intestinal epithelial cells, but I am not convinced that STM0233 and ChiA are involved. If the process is driven by invading Salmonella bacteria, then the changes induced by STM0233 and ChiA could simply be due to differences in invasion (Fig. S6). I don’t think the entire glycomics survey should be repeated with an invasion-deficient strain or in the presence of cytochalasin D. However, one simple experiment would be to quantify one or two putative substrate on epithelial cells and rule out that invasion per se is a driver of the observed changes. At a minimum, this limitation could be discussed in the text.

Reviewer #2: 1- Throughout the study authors investigate the binding of Salmonella to ileum or colon using in vitro and in vivo studies. One would expect that reduced Salmonella adhesion, invasion and dissemination would be also reflected to reduced cytokine profiles in the tissues where the author see an effect of chitinases such as ileum. It is not clear why the authors they chose to use the cecal tissue to investigate the cytokine production. It is not suprising that they do not observe major changes in the cecal cytokine profiles at one time point except increased levels of il17a production in the animals infected by the chitinase mutants. It would be more informatory to study the cytokine profiles in the relevant ileal tissue or even peyers patches to show whether the chitinases effect on tissue invasion would reflect to the cytokine expression in these tissues.

2- Can the authors test the pef mutant in vitro to see whether pef fimbriae binds to the the exposed Lewis X glycans? This experiment would increase the impact of the paper if the authors can make that small but very important mechanistic link.

Reviewer #3: None

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: Line 128: As written, it seems somewhat contradictory to me that the authors seek to investigate the role of chitinase activity during “Salmonella infection” and then assay transcription under laboratory conditions – maybe this could be reworded.

Fig. 1D and E: I am somewhat surprised that the invA mutant is recovered in lower numbers than the wild type. Would one expect that both strains are recovered in equal numbers after the cytochalasin D treatment since they both should adhere in a similar manner? It might be useful for the reader if the authors could discuss this potential caveat in the text.

Fig. 4: The y-axis is labelled as “arbitrary units” – aren’t these fold changes over untreated control mice?

Reviewer #2: The double mutant is only referred to as Δ2 only in Fig 4A through out the manuscript. It would be better for consistency to change it to ΔSTM0233 ΔchiA

If there is a more methodical way to show the glycan data to help the reader understand the different glycans, it would really help the manuscript. Not the clarity but it is difficult to digest this data for someone who is nor familiar with glycans. The little images by the graphs are a good idea though.

Reviewer #3: 1. Line 181 – Are the genes expression upregulated compared to expression in LB? If so, how does the expression of the normalizing gene change between LB an luminal content? I would suggest presenting the data as total copy numbers of mRNA (cDNA) per ml/gr/cfu, which would be a more informative.

2. Line 248 – change to Fig 2D

3. The authors discuss previous studies demonstrating only a minor contribution to chiA for invasion (lines 300-307). It should be worth mentioning in the text that one possible explanation could be redundancy, as the two chitinases investigated in the current work clearly present (Fig 1 & Fig 3), which might be overlooked in other studies.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Decision Letter 1

Andreas J Baumler, Brian K Coombes

23 Mar 2022

Dear Dr. Behnsen,

We are pleased to inform you that your manuscript 'Salmonella enterica serovar Typhimurium chitinases modulate the intestinal glycome and promote small intestinal invasion.' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Andreas J Baumler

Associate Editor

PLOS Pathogens

Brian Coombes

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Acceptance letter

Andreas J Baumler, Brian K Coombes

6 Apr 2022

Dear Dr. Behnsen,

We are delighted to inform you that your manuscript, "Salmonella enterica serovar Typhimurium chitinases modulate the intestinal glycome and promote small intestinal invasion.," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Deletion of S. Typhimurium chitinases does not affect growth characteristics.

    (A) Growth of S. Typhimurium strains in LB broth at 37°C. WT n = 5, chitinase-deficient strains n = 3. Points represent geometric mean ± geometric SD. (B) Growth of S. Typhimurium strains in M9 minimal medium +0.4% colloidal chitin at 37°C. n = 3. Points represent geometric mean ± geometric SD. Statistics: Mixed-effect analysis and Tukey’s multiple comparisons test.

    (TIFF)

    S2 Fig. Complementation of chitinase-deficient strains restores invasion.

    Chitinase genes were inserted into the Tn7 locus of chitinase-deficient S. Typhimurium. Gentamicin protection assay of S. Typhimurium infected (MOI:1) small intestinal epithelial cells (IPEC-1). (A) Invasion of ΔchiA and chiA complemented strain. n = 8. (B) Invasion of ΔSTM0233 and STM0233 complemented strain. n = 8. (C) Invasion of ΔSTM0233 ΔchiA (Δ2) and Δ2 strain complemented with chiA or STM0233. n = 6. Percent recovery of each strain was normalized to WT recovery. Bars represent mean ± SEM. Statistics: One-way ANOVA with Dunnett’s multiple comparison test.

    (TIFF)

    S3 Fig. Cytochalasin D treatment completely blocks S. Typhimurium invasion.

    (A) Gentamicin protection assay of S. Typhimurium infected (MOI:1) colonic epithelial cells (T84) after treatment of epithelial cells with cytochalasin D (1–2 μg/mL). (B) Gentamicin protection assay of S. Typhimurium infected (MOI:1) small intestinal epithelial cells (IPEC-1) after treatment of epithelial cells with cytochalasin D (2 μg/mL). n = 2. Bars represent mean ± SD.

    (TIFF)

    S4 Fig. S. Typhimurium chitinases are not required for late-stage infection.

    (A) Streptomycin pre-treatment mouse model of 96 h S. Typhimurium infection. (B) Luminal samples from the terminal ileum were collected at 96 hpi to determine S. Typhimurium colonization. Invasion was determined with a gentamicin protection assay performed on the terminal ileum. WT n = 3, ΔSTM0233 n = 3, ΔchiA n = 4. (C) S. Typhimurium colonies recovered from fecal samples collected at 24, 48, and 72 hpi. Fecal samples at 96 hpi were collected directly from the lumen of the colon. Invasion of colonic tissue was determined with a gentamicin protection assay. WT n = 10, ΔSTM0233 n = 8, ΔchiA n = 8. (D) Colonization of the Peyer’s patches, mesenteric lymph nodes, spleen, and liver after 96 h of intragastric infection. WT n = 10, ΔSTM0233 n = 8, ΔchiA n = 8. Bars represent geometric mean ± geometric SD. Statistics: (B-D) Stars indicate significance compared to the WT control by one-way ANOVA with Dunnett’s multiple comparison test. * = p<0.05.

    (TIFF)

    S5 Fig. Representative images of cecum and ileum histology.

    Uninfected: (A) & (B) Cecum–intestine intact without any signs of inflammation [A: low power, hematoxylin eosin, original magnification 40x; B: intermediate power, hematoxylin-eosin, original magnification 200x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin eosin, original magnification 40x; D: intermediate power, hematoxylin eosin, original magnification 200x]. WT: (A) & (B) Cecum–moderate inflammation (moderate submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: high power, hematoxylin-eosin, original magnification 400x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x]. ΔSTM0233: (A) & (B) Cecum–moderate inflammation (moderate submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: intermediate power, hematoxylin-eosin, original magnification 200x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x]. ΔchiA: (A) & (B) Cecum–moderate inflammation (profound submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: intermediate power, hematoxylin-eosin, original magnification 200x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x]. ΔSTM0233 ΔchiA: (A) & (B) Cecum–moderate inflammation (moderate submucosal edema with lamina propria neutrophilic infiltration with cryptitis, crypt abscess and decrease in goblet cells) [A: low power, hematoxylin-eosin, original magnification 40x; B: high power, hematoxylin- eosin, original magnification 400x]. (C) & (D) Ileum–intestine intact without any signs of inflammation [C: low power, hematoxylin-eosin, original magnification 40x; D: intermediate power, hematoxylin-eosin, original magnification 200x].

    (TIFF)

    S6 Fig. Innate immune gene expression in infected ileal tissue.

    (A-E) mRNA expression of innate immune genes extracted from ileal tissue of S. Typhimurium infected mice 48 hpi. Expression is normalized to the housekeeping gene actb as well as gene expression in uninfected mice. n = 8 per group. Bars represent geometric mean ± geometric SD. There was no statistical significance (α = 0.05) comparing groups to the WT control by one-way ANOVA with Dunnett’s multiple comparison test.

    (TIFF)

    S7 Fig. Chitinase-deficient strains maintained invasion defects for glycome analysis.

    Gentamicin protection assay of S. Typhimurium infected IPEC-1 cells (MOI:1000) done concurrently with infection for the glycome analysis. n = 2. Bars represent mean ± SD.

    (TIFF)

    S8 Fig. N-linked glycan identification using MS data.

    Examples of (A) complex and (B) high-mannose N-glycan identification through full MS and MS2. Insets are full MS spectra showing isotopic distribution envelops. The N-glycan compositions are identified through full MS within an m/z accuracy of 10 ppm. The putative N-glycan structures are further confirmed by matching the fragment ions detected in MS2 spectra.

    (TIFF)

    S1 Table. Bacterial strains and plasmids used.

    (XLSX)

    S2 Table. Primers used for cloning.

    (XLSX)

    S3 Table. Primers used for RT-qPCR.

    (XLSX)

    S4 Table. Relative abundance of all glycan species identified in glycome analysis.

    Average relative abundance of glycan species after infecting IPEC-1 cells with S. Typhimurium for 1 h (MOI:1000). Uninfected n = 14, WT n = 6, ΔSTM0233 n = 6, ΔchiA n = 6, ΔSTM0233 ΔchiA n = 6. Relative abundance is calculated by dividing glycan species abundance by total glycan abundance. Raw data has been uploaded to GlycoPOST database [63], accession number GPST000225.

    (XLSX)

    S1 Data. Numerical data used for statistical analysis.

    Excel sheet containing the numerical data for Figs 1A–1E, 2B–2D, 3A and 3B, 4A–4M, 5A–5C, 6F, S1A and S1B, S2A–S2C, S3A and S3B, S4B–S4D, S6A–S6E, and S7.

    (XLSX)

    Attachment

    Submitted filename: PPATHOGENS-D-21-02439R1 - Response to Reviewers.pdf

    Data Availability Statement

    Glycome analysis data set is available in the GlycoPOST repository via the accession number GPST000225. All other relevant data is present within this manuscript.


    Articles from PLoS Pathogens are provided here courtesy of PLOS

    RESOURCES